Marketing Analysis of Hemostatic Drugs in China from 2006 to 2008 / 中国药房

OBJECTIVE:To evaluate the marketing of hemostatic drugs use in China from 2006 to 2008.METHODS:By reviewing literature both at home and abroad and combining the data of the sales volume and consumption sum of hemostatic drugs from 2006 to 2008 and in the first 3 quarters of 2008 available in the "State Medicine Economy Information Network",the drug variety and manufacturers were analyzed statistically.RESULTS & CONCLUSIONS:Hemopexin assumed a dominate place in the market of hemostatic drugs,accounting for 38% of total in sales value,followed by tranexamic acid and aprotinin.Switzerland Sugao pharmaceutical factory ranked at the first place in terms of sales value of hemostatic drugs.